Yolanda Cifuentes

Yolanda Cifuentes

Auto-generated profile, based on publicly available information

Yolanda Cifuentes

Universidad Nacional de Colombia

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2008 in Revista de Salud Pública
Verified
Journal Article
Closed access
PDF file
YCYolanda Cifuentes-Cifuentes
Yolanda Cifuentes-Cifuentes
CAClara Arteaga-Díaz
Clara Arteaga-Díaz
CIClementina Infante-Contreras
Clementina Infante-Contreras
ECElsa G. Clavijo-López
Elsa G. Clavijo-López
CQConstanza Quintero-Guzmán
Constanza Quintero-Guzmán
Determining the frequency and characteristics of newborn suffering craniofacial abnormalities who were attending the Instituto Materno Infantil (IMI) in Bogotá. Data was gathered regarding the newborn suffering such alterations who attended IMI from March 1st 2000 to August 15th 2001. The variables analysed were: being born in or having been remitted to the IMI, social strata, origin, general and specific risk factors, gender, correlation between weight and gestational age, clinical and aetiological diagnosis of the anomaly, karyotype and condition on leaving IMI. There was 2.7% prevalence for congenital defects and 0.6% for craniofacial abnormalities. 69% of the 52 patients had specific risk factors, 38% had been preterm, 33% had suffered retarded intra-uterine growth, 65% had cleft palates, 55.8% multiple abnormalities and 46% syndromes. Aetiological diagnosis was established in 38%; 12% had chromosomopathy. Eighteen children (35%) died, death being attributed to their defect in 13 of them, six by chromosomopathy. This study revealed the use of karyotype in making an aetiological diagnosis and determining prognosis. Mortality for the group suffering craniofacial abnormalities was threefold that of other hospitalised neonatal patients. Significant statistical association was shown between mortality and preterm condition, retarded growth, chromosomopathy and a diagnosis of multiple defects and/or syndromes. Prematurity, retarded growth, multiple defects, syndrome diagnosis and chromosomopathy revealed a mortality risk profile.

1 July 2005 in Revista de Salud Pública
Verified
Journal Article
Open access
PDF file
YCYolanda Cifuentes
Yolanda Cifuentes
ARAriel Iván Ruiz.
Ariel Iván Ruiz.
ALAura Lucia Leal
Aura Lucia Leal
LMLiliana Muñoz
Liliana Muñoz
MHMaria Herrera
Maria Herrera
LJLuz Jiménez
Luz Jiménez
Investigating the prevalence and sensitivity of germs isolated from newborn in a referral hospital in Bogotá. Suggesting an empirical antibiotic treatment for neonatal infection. Cultures taken between February and December 2002 were analysed. Blood cultures were processed using BacT/ALERT (Durham, NC), urine cultures by UROCULT (Bio-Bacter) and catheter tips in thioglycollate. BBL CRYSTAL identification system (BD, Sparks, MD) was used for identifying germs. Antibiotic sensitivity was determined by disk diffusion. There were 1,097 positive aerobic and facultative aerobic germ cultures; 64.3% were Gram-positive, 30.6% Gram-negative and 4.9% were yeasts. Gram-positive germs consisted of coagulase-negative staphylococci (64.2%), enterococcus (13.8%) and coagulase-positive staphylococci (13.3%). The most frequent Gram-negatives were Klebsiella (45.2%), Eschericha coli (30.9%) and Serratia (10.1%). Staphylococcus epidermidis accounted for 64% of the coagulase-negative staphylococci. S. epidermidis susceptibility to vancomycin was 100%. Coagulase-negative staphylococci susceptibility to rifampin and amikacin was 59% and 67.4% (respectively). Coagulase-negative staphylococci resistance to beta-lactams was 86.4% (95% CI: 82.3-89.9). Coagulase-positive staphylococci sensitivity to vancomycin was 100%. Gram-negative susceptibility to imipenem was 98.1% (95% CI: 89.9-99.9), 78.1% to gentamicin (95% CI: 64.9-88.2) and 46.6% to amikacin (95% CI: 28.3-65.7). There was high coagulase-negative staphylococci prevalence in neonatal infection (particularly S. epidermidis). All S. epidermidis and coagulase-positive staphylococci were sensitive to vancomycin. There was increasing coagulase-negative staphylococci and Gram-negative resistance to oxacillin and amikacin, respectively.

3 August 2022 in Case reports
Verified
Journal Article
Open access
PDF file
MCMery Yolanda Cifuentes Cifuentes
Mery Yolanda Cifuentes Cifuentes
LALinda Stefany Gómez Aristizábal
Linda Stefany Gómez Aristizábal
GBGladys Pinilla Bermúdez
Gladys Pinilla Bermúdez
CCClaudia Andrea Cruz
Claudia Andrea Cruz
JNJeannette Navarrete
Jeannette Navarrete
Introduction: Congenital syphilis is a major public health problem, and early diagnosis and treatment are necessary to prevent it. Penicillin G benzathine is the treatment of choice in pregnant women; however, it may fail to prevent fetal infection, as in the present case. Case presentation: Male newborn, son of an HIV negative mother with gestational syphilis (venereal disease research laboratory (VDRL) 1:4 dilution, positive treponemal test) diagnosed at week 21 of gestation and treated with three doses of 2 400 000 IU of penicillin G benzathine. At delivery, the mother presented VDRL 1:1 dilution. The newborn was diagnosed with congenital syphilis due to VDRL 1:4 dilution, positive treponemal test, elevated aspartate aminotransferases, hyposthenuria, proteinuria, hematuria, and leukocyturia that resolved after treatment with crystalline penicillin for 10 days. The molecular testing in blood showed a high treponemal load. The VDRL test at 3 months was non-reactive. Conclusions: Preventing congenital syphilis with the recommended treatment for gestational syphilis may fail. Moreover, diagnosing this condition in an asymptomatic newborn is difficult. Therefore, clinical and serological tests are recommended to confirm whether maternal treatment was effective in the fetus.

1 June 2013
Verified
Journal Article
Closed access
MCMery Y Cifuentes-Cifuentes
Mery Y Cifuentes-Cifuentes
COCindy V Ojeda-Enríquez
Cindy V Ojeda-Enríquez

1 January 2020 in Case reports
Verified
Journal Article
Open access
PDF file
YCYolanda Cifuentes
Yolanda Cifuentes
CAClara Arteaga
Clara Arteaga
Introduction: Inborn errors of metabolism have significant morbidity and mortality rates in the neonatal period. One of these disorders is defective peroxisomal biogenesis, which causes complex and severe clinical pictures because peroxisomes are present in all nucleated cells of mammals. Case presentation: This is the case of a newborn with dysmorphic features who had seizures at birth and presented with neurological, liver, kidney and heart involvement during her 20 days of life. Necropsy confirmed liver and kidney involvement, which, together with family history of death of a sibling and a cousin, led to suspect a peroxisomal disease that was confirmed by the biochemical alterations observed. Discussion: Dysmorphism and seizures at birth may be an expression of a metabolic disease. The findings of the physical examination and the demonstration of liver, kidney and heart involvement are consistent with the initial description of Zellweger syndrome; the biochemical alterations are conclusive. Conclusions: It is necessary to define if dysmorphism is an isolated finding or if there is involvement of other organ(s) or system(s) to establish a suitable diagnosis of peroxisome biogenesis. Inborn errors of metabolism should be included in the diagnosis of dysmorphic newborns when several organs are involved, since their identification enables genetic counseling.

1 March 2008
Verified
Journal Article
Closed access
YCYolanda Cifuentes
Yolanda Cifuentes
IHIsabel De La Hoz
Isabel De La Hoz
MBMartha Bermúdez
Martha Bermúdez
CAClara Arteaga
Clara Arteaga